Ergoteles LLC Biomarin Pharmaceutical Inc Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $2.21 Million - $2.97 Million	27,332 New	27,332 $2.83 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $3.62 Million - $4.14 Million	-48,403 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$75.51 - $84.79 $3.65 Million - $4.1 Million	48,403 New	48,403 $4.04 Million
Q1 2021 May 12, 2021	SELL	$74.73 - $90.69 $12.6 Million - $15.3 Million	-169,200 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$72.61 - $90.2 $12.3 Million - $15.3 Million	169,200 New	169,200 $14.8 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.